Results Demonstrate HIP-Engineered Primary Pancreatic Islet Cells Avoid Immune Detection, Function, and Persist after Intramuscular Transplantation in First Treated Patient with Type 1 Diabetes ...

NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that on January 6, 2025, the Compensation Committee of the Board of Directors ...

Presentation to feature an update on the Company’s novel continuous blood glucose monitor for patients with diabetesRUTHERFORD, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: GCTK) (“Glucotrack” or ...

WuXi upgraded its WuXiBody platform in bispecific antibody discovery to address the growing global demand for these complex ...

MAIA Biotechnology's shares rose 19% to $2.46 after the company said it entered into a clinical supply agreement with BeiGene to evaluate THIO, MAIA's telomere-targeting anticancer agent.

BIOS/UEFI vulnerabilities in the iSeq 100 DNA sequencer from U.S. biotechnology company Illumina could let attackers disable ...

WuXi AppTec, the Shanghai-based biotech giant, has sold its South Philly-based WuXi Advanced Therapies contract manufacturing ...

MedicosBiotech proudly announces its recognition at CES 2025, the world's premier technology event, as a recipient of the ...

The primary analysis included 186 subjects who received the therapy and 139 subjects who were given a placebo.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Upstream's breeding technologies, which protect plants from yield-threatening diseases, have already delivered strong results ...

In a new peer reviewed analysis, scientists quantify amino acids before and after our “last universal common ancestor.” The ...